Olanzapine versus other atypical antipsychotics for schizophrenia.

@article{Komossa2010OlanzapineVO,
  title={Olanzapine versus other atypical antipsychotics for schizophrenia.},
  author={Katja Komossa and Christine Rummel-Kluge and Heike Hunger and Franziska Schmid and Sandra Schwarz and Lorna Duggan and Werner Kissling and Stefan Leucht},
  journal={The Cochrane database of systematic reviews},
  year={2010},
  volume={3},
  pages={
          CD006654
        }
}
BACKGROUND In many countries of the industrialised world second generation ("atypical") antipsychotics have become the first line drug treatment for people with schizophrenia. The question as to whether, and if so how much, the effects of the various second generation antipsychotics differ is a matter of debate. In this review we examined how the efficacy and tolerability of olanzapine differs from that of other second generation antipsychotics. OBJECTIVES To evaluate the effects of… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 100 CITATIONS, ESTIMATED 58% COVERAGE

Subchronic olanzapine treatment decreases the expression of pancreatic glucose transporter 2 in rat pancreatic β cells

  • Journal of Endocrinological Investigation
  • 2014
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Psychopharmaka und Diabetes

VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Olanzapine Long-Acting Injection

VIEW 5 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011

  • The Australian and New Zealand journal of psychiatry
  • 2013
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2008
2019

CITATION STATISTICS

  • 5 Highly Influenced Citations

  • Averaged 6 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 77 REFERENCES

The treatment of negative symptoms and deficit states of chronic schizophrenia : olanzapine compared to amisulpride and placebo in a 6 - month double - blind controlled clinical trial

JP McEvoy
  • Acta Psychiatrica Scandinavica
  • 2006
VIEW 45 EXCERPTS
HIGHLY INFLUENTIAL

A rating scale for drug-induced akathisia.

  • The British journal of psychiatry : the journal of mental science
  • 1989
VIEW 28 EXCERPTS
HIGHLY INFLUENTIAL

Continued) Notes Risk of bias Bias

Van Nimwegen
  • 2006
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Trial name or title Trial 10769 F1D-US-HGMN Methods

Eli Lilly
  • 2006
VIEW 26 EXCERPTS
HIGHLY INFLUENTIAL

2004b Trial name or title Trial 8894 F1D-US-HGLR

Eli Lilly
  • 2004
VIEW 26 EXCERPTS
HIGHLY INFLUENTIAL

2003a Trial name or title Trial 8047 F1D-MC-HGLB Methods

Eli Lilly
  • 2003
VIEW 26 EXCERPTS
HIGHLY INFLUENTIAL